Effectiveness of different strenghts of topical steroids in children with eczema in general practice.
- Conditions
- Atopic dermatitis
- Registration Number
- NL-OMON21308
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
In order to be eligible to participate in the cohort study (and possibly be
eligible for the trial), a subject must meet all of the following criteria:
Exclusion Criteria
A potential patient who meets any of the following criteria will be
excluded from participation in the cohort study:
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome will be change in subjective disease severity after 24 weeks follow-up in the trial, measured with Patient-Oriented Eczema Measure (POEM) questionnaire.
- Secondary Outcome Measures
Name Time Method Secondary outcomes concerning trial<br /><br>-Changes in subjective disease severity after 1 week and 4 weeks of FU (POEM)<br /><br>-Changes in objective disease severity after 1 week, 4 weeks and 24 weeks of FU (EASI)<br /><br>-Quality of life with the IDQOL or CDLQI depending on age<br /><br>-Compliance<br /><br>-Local side-effects<br /><br>-Systemic side-effects<br /><br>-Time to recovery<br /><br>-Frequency of flare-ups<br /><br>-Medication use<br /><br>-Healthcare use